CHEK1 and cancer: Jia et al. (2020) reported that the downregulation of LINC-PINT is associated with cancer cell growth and invasion. LINC-PINT inhibited DNA damage repair via the ATM/ATR-Chk1/Chk2 signaling pathways (Wang et al., 2021).